Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bernaldo de Quirós Fernández, Sandra"'
Autor:
Teplensky, Michelle H., Fantham, Marcus, Poudel, Chetan, Hockings, Colin, Lu, Meng, Guna, Alina, Aragones-Anglada, Marta, Moghadam, Peyman Z., Li, Peng, Farha, Omar K., Bernaldo de Quirós Fernández, Sandra, Richards, Frances M., Jodrell, Duncan I., Kaminski Schierle, Gabriele, Kaminski, Clemens F., Fairen-Jimenez, David
Publikováno v:
In Chem 14 November 2019 5(11):2926-2941
Autor:
Wallez, Yann, Dunlop, Charles R, Johnson, Timothy Isaac, Koh, Siang-Boon, Fornari, Chiara, Yates, James WT, Bernaldo De Quirós Fernández, Sandra, Lau, Alan, Richards, Frances M, Jodrell, Duncan I
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, and overall survival rates have barely improved over the past five decades. The antimetabolite gemcitabine remains part of the standard of care but shows very limited antitumor e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1963a5db73d1b1d42d36284aab762918
https://www.repository.cam.ac.uk/handle/1810/280126
https://www.repository.cam.ac.uk/handle/1810/280126
Autor:
Koh, Siang-Boon, Wallez, Yann, Dunlop, Charles R, Bernaldo De Quirós Fernández, Sandra, Bapiro, Tashinga E, Richards, Frances M, Jodrell, Duncan I
Combination of cytotoxic therapy with emerging DNA damage response inhibitors (DDRi) has been limited by tolerability issues. However, the goal of most combination trials has been to administer DDRi with standard-of-care doses of chemotherapy. We hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8966db395e2773c00603dddfae497c5
https://www.repository.cam.ac.uk/handle/1810/277661
https://www.repository.cam.ac.uk/handle/1810/277661
Autor:
Dunlop, Charles R., Wallez, Yann, Johnson, Timothy Isaac, Bernaldo de Quirós Fernández, Sandra, Durant, Stephen T., Cadogan, Elaine B., Lau, Alan, Richards, Frances M., Jodrell, Duncan I.
Publikováno v:
British Journal of Cancer; Oct2020, Vol. 123 Issue 9, p1424-1436, 13p
Autor:
Dunlop, Charles R., Wallez, Yann, Bernaldo de Quirós Fernández, Sandra, Lau, Alan, Richards, Frances M., Jodrell, Duncan I.
Publikováno v:
In Pancreatology December 2020 20(8):e7-e7
Autor:
Wallez Y; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. Yann.Wallez@cruk.cam.ac.uk Fran.Richards@cruk.cam.ac.uk., Dunlop CR; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Johnson TI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Koh SB; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Fornari C; Safety and ADME Translational Sciences Department, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Yates JWT; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Bernaldo de Quirós Fernández S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Lau A; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Richards FM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. Yann.Wallez@cruk.cam.ac.uk Fran.Richards@cruk.cam.ac.uk., Jodrell DI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2018 Aug; Vol. 17 (8), pp. 1670-1682. Date of Electronic Publication: 2018 Jun 11.
Autor:
Koh SB; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. siangboon.koh@cantab.net.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wallez Y; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Dunlop CR; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Bernaldo de Quirós Fernández S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Bapiro TE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Richards FM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Jodrell DI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2018 Jun 01; Vol. 78 (11), pp. 3054-3066. Date of Electronic Publication: 2018 May 07.